InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (30 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
30
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Harmon Cyrus, Chief Technology Officer. Officer active across 1 company, notably Olema Pharmaceuticals, Inc.. In total, 32 disclosures have been published. Split: 0 buy · 30 sells. Total volume traded: €4.8m. History available since 18 June 2021. The latest transaction was disclosed on 23 July 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Harmon Cyrus
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
12,500 shares@ US$11.5790.014% mcap2.6% of flowCommon StockSEC:0001831410-26-000008:0
12,500 shares@ US$11.7140.014% mcap2.6% of flowCommon StockSEC:0001831410-26-000008:1
10,000 shares@ US$26.885.1% of flowCommon StockSEC:0001831410-26-000004:0
3,489 shares@ US$29.121.9% of flowCommon StockSEC:0001831410-26-000002:0
2,881 shares@ US$28.531.7% of flowCommon StockSEC:0001831410-25-000007:0
10,000 shares@ US$8.041.6% of flowCommon StockSEC:0001831410-25-000004:0
29,250 shares0Common StockSEC:0001415889-24-029028:0
4,066 shares@ US$15.581.1% of flowCommon StockSEC:0001415889-24-020461:0
5,000 shares@ US$12.261.1% of flowCommon StockSEC:0001415889-24-019528:0
20,000 shares@ US$10.773.9% of flowCommon StockSEC:0001415889-24-018975:0
15,000 shares@ US$9.412.5% of flowCommon StockSEC:0001415889-24-015508:0
5,000 shares@ US$10.921.0% of flowCommon StockSEC:0001415889-24-012485:0
15,000 shares@ US$9.512.6% of flowCommon StockSEC:0001415889-24-012020:0
20,000 shares@ US$10.973.9% of flowCommon StockSEC:0001415889-24-009445:0
24,900 shares@ US$12.415.5% of flowCommon StockSEC:0001415889-24-006322:0
25,000 shares@ US$12.235.4% of flowCommon StockSEC:0001415889-24-002350:0
22,500 shares@ US$13.305.2% of flowCommon StockSEC:0001415889-24-000070:0
25,000 shares@ US$12.575.5% of flowCommon StockSEC:0001415889-23-015701:0
15,750 shares0Common StockSEC:0001415889-23-015457:0
25,000 shares@ US$12.055.5% of flowCommon StockSEC:0001415889-23-014714:0
25,000 shares@ US$12.415.7% of flowCommon StockSEC:0001415889-23-013898:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012898:0
15,000 shares@ US$9.362.5% of flowCommon StockSEC:0001415889-23-012922:0
15,000 shares@ US$10.142.7% of flowCommon StockSEC:0001415889-23-012360:0
10,000 shares@ US$6.301.1% of flowCommon StockSEC:0001415889-23-009522:0
25 of 32 declarations
About Harmon Cyrus
Harmon Cyrus is Directeur Technique and a Director at Olema Pharmaceuticals, Inc. The 30 filings recorded are all sales, with 0 EUR of purchases and 4,559,351 EUR of sales in the sampled filings, from 2021-06-21 to 2026-01-21.
